Our research emphasizes developing and using novel molecular tools to address outstanding questions in infectious diseases. Our specific focus is on malaria and the causative pathogen, Plasmodium falciparum. We take advantage of model systems to efficiently validate and optimize the design of new tools intended to address unmet needs in our target pathogen. In this process, we simultaneously produce solutions that are applicable across a range of model and pathogenic organisms, and broadly useful in both basic and applied biology efforts.
We are highly multi-disciplinary in our approach, and integrate expertise in diverse areas including: biomolecular engineering; chemical biology; synthetic biology; analytical chemistry; biochemistry; and molecular and cell biology.